nodes	percent_of_prediction	percent_of_DWPC	metapath
Udenafil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.112	0.118	CbGbCtD
Udenafil—CYP3A5—Carbamazepine—epilepsy syndrome	0.0703	0.0741	CbGbCtD
Udenafil—CYP3A5—Phenytoin—epilepsy syndrome	0.063	0.0664	CbGbCtD
Udenafil—CYP3A5—Phenobarbital—epilepsy syndrome	0.0562	0.0592	CbGbCtD
Udenafil—CYP3A5—Midazolam—epilepsy syndrome	0.0554	0.0584	CbGbCtD
Udenafil—CYP3A5—Diazepam—epilepsy syndrome	0.0533	0.0561	CbGbCtD
Udenafil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0436	0.046	CbGbCtD
Udenafil—CYP3A5—Valproic Acid—epilepsy syndrome	0.042	0.0442	CbGbCtD
Udenafil—CYP3A4—Felbamate—epilepsy syndrome	0.0406	0.0427	CbGbCtD
Udenafil—CYP3A4—Trimethadione—epilepsy syndrome	0.0406	0.0427	CbGbCtD
Udenafil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0381	0.0402	CbGbCtD
Udenafil—CYP3A4—Clonazepam—epilepsy syndrome	0.0345	0.0363	CbGbCtD
Udenafil—CYP3A4—Clobazam—epilepsy syndrome	0.0331	0.0348	CbGbCtD
Udenafil—CYP3A4—Rufinamide—epilepsy syndrome	0.0281	0.0296	CbGbCtD
Udenafil—CYP3A4—Carbamazepine—epilepsy syndrome	0.0274	0.0289	CbGbCtD
Udenafil—CYP3A4—Primidone—epilepsy syndrome	0.0256	0.027	CbGbCtD
Udenafil—CYP3A4—Phenytoin—epilepsy syndrome	0.0246	0.0259	CbGbCtD
Udenafil—CYP3A4—Propofol—epilepsy syndrome	0.0229	0.0242	CbGbCtD
Udenafil—CYP3A4—Acetazolamide—epilepsy syndrome	0.0219	0.0231	CbGbCtD
Udenafil—CYP3A4—Phenobarbital—epilepsy syndrome	0.0219	0.0231	CbGbCtD
Udenafil—CYP3A4—Midazolam—epilepsy syndrome	0.0216	0.0228	CbGbCtD
Udenafil—CYP3A4—Diazepam—epilepsy syndrome	0.0208	0.0219	CbGbCtD
Udenafil—CYP3A4—Zonisamide—epilepsy syndrome	0.0203	0.0214	CbGbCtD
Udenafil—CYP3A4—Valproic Acid—epilepsy syndrome	0.0164	0.0173	CbGbCtD
Udenafil—CYP3A4—Topiramate—epilepsy syndrome	0.0148	0.0156	CbGbCtD
Udenafil—PDE5A—cGMP effects—KCNMA1—epilepsy syndrome	0.00448	0.0921	CbGpPWpGaD
Udenafil—PDE5A—Nitric oxide stimulates guanylate cyclase—KCNMA1—epilepsy syndrome	0.00356	0.0731	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—SLC8A2—epilepsy syndrome	0.00241	0.0496	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—SLC8A3—epilepsy syndrome	0.0023	0.0473	CbGpPWpGaD
Udenafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS1—epilepsy syndrome	0.00216	0.0443	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—KCNMA1—epilepsy syndrome	0.00139	0.0285	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—SLC8A1—epilepsy syndrome	0.00137	0.0281	CbGpPWpGaD
Udenafil—Sildenafil—CYP2C19—epilepsy syndrome	0.00136	0.574	CrCbGaD
Udenafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—epilepsy syndrome	0.00129	0.0264	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—ATP2A2—epilepsy syndrome	0.00105	0.0216	CbGpPWpGaD
Udenafil—CYP3A5—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00101	0.0208	CbGpPWpGaD
Udenafil—Sildenafil—CYP2D6—epilepsy syndrome	0.00101	0.426	CrCbGaD
Udenafil—CYP3A5—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000859	0.0177	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—NOS1—epilepsy syndrome	0.00084	0.0173	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—DOCK7—epilepsy syndrome	0.0008	0.0164	CbGpPWpGaD
Udenafil—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000735	0.0151	CbGpPWpGaD
Udenafil—CYP3A5—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000712	0.0146	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—LAMP2—epilepsy syndrome	0.000652	0.0134	CbGpPWpGaD
Udenafil—CYP3A5—Xenobiotics—CYP2C19—epilepsy syndrome	0.00063	0.0129	CbGpPWpGaD
Udenafil—CYP3A5—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000606	0.0124	CbGpPWpGaD
Udenafil—CYP3A5—Xenobiotics—CYP2D6—epilepsy syndrome	0.000565	0.0116	CbGpPWpGaD
Udenafil—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000546	0.0112	CbGpPWpGaD
Udenafil—CYP3A5—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000543	0.0112	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—SLC8A2—epilepsy syndrome	0.000541	0.0111	CbGpPWpGaD
Udenafil—CYP3A5—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000522	0.0107	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—SLC8A3—epilepsy syndrome	0.000516	0.0106	CbGpPWpGaD
Udenafil—PDE5A—Platelet homeostasis—NOS2—epilepsy syndrome	0.000501	0.0103	CbGpPWpGaD
Udenafil—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00047	0.00966	CbGpPWpGaD
Udenafil—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000456	0.00937	CbGpPWpGaD
Udenafil—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000432	0.00889	CbGpPWpGaD
Udenafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000402	0.00827	CbGpPWpGaD
Udenafil—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.0004	0.00821	CbGpPWpGaD
Udenafil—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.00039	0.00802	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—TEK—epilepsy syndrome	0.000348	0.00716	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000337	0.00692	CbGpPWpGaD
Udenafil—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000331	0.0068	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—FLNA—epilepsy syndrome	0.000328	0.00673	CbGpPWpGaD
Udenafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000314	0.00645	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—KCNMA1—epilepsy syndrome	0.000311	0.00638	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—SLC8A1—epilepsy syndrome	0.000307	0.0063	CbGpPWpGaD
Udenafil—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	0.000293	0.00602	CbGpPWpGaD
Udenafil—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000282	0.00579	CbGpPWpGaD
Udenafil—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000277	0.00569	CbGpPWpGaD
Udenafil—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	0.000263	0.0054	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000261	0.00537	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.00026	0.00534	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000258	0.0053	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PPIA—epilepsy syndrome	0.000258	0.0053	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000256	0.00527	CbGpPWpGaD
Udenafil—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000253	0.00519	CbGpPWpGaD
Udenafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000243	0.00499	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—ATP2A2—epilepsy syndrome	0.000235	0.00484	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000235	0.00482	CbGpPWpGaD
Udenafil—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000231	0.00476	CbGpPWpGaD
Udenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000231	0.00475	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—ITGA2—epilepsy syndrome	0.000228	0.00469	CbGpPWpGaD
Udenafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.000213	0.00439	CbGpPWpGaD
Udenafil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000213	0.00438	CbGpPWpGaD
Udenafil—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000212	0.00436	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000212	0.00436	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000211	0.00433	CbGpPWpGaD
Udenafil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000201	0.00413	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—ADRA2A—epilepsy syndrome	0.000201	0.00413	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PLAT—epilepsy syndrome	0.0002	0.00411	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00019	0.00391	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—NOS1—epilepsy syndrome	0.000188	0.00387	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—AKT3—epilepsy syndrome	0.000176	0.00362	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PLAUR—epilepsy syndrome	0.000174	0.00358	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—CDC42—epilepsy syndrome	0.000161	0.0033	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000156	0.00322	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—FYN—epilepsy syndrome	0.000143	0.00294	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—YWHAZ—epilepsy syndrome	0.000138	0.00283	CbGpPWpGaD
Udenafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000129	0.00265	CbGpPWpGaD
Udenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000123	0.00252	CbGpPWpGaD
Udenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000122	0.00252	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PLAU—epilepsy syndrome	0.000122	0.00251	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000122	0.0025	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000121	0.00248	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00012	0.00247	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000119	0.00245	CbGpPWpGaD
Udenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000115	0.00236	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—PRKCB—epilepsy syndrome	0.000114	0.00233	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP2C19—epilepsy syndrome	0.000113	0.00231	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—NOS2—epilepsy syndrome	0.000112	0.00231	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP11A1—epilepsy syndrome	0.000112	0.0023	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000111	0.00228	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.00011	0.00227	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000109	0.00224	CbGpPWpGaD
Udenafil—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000108	0.00221	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—CYP2D6—epilepsy syndrome	0.000101	0.00208	CbGpPWpGaD
Udenafil—CYP3A5—Metapathway biotransformation—CYP2D6—epilepsy syndrome	9.96e-05	0.00205	CbGpPWpGaD
Udenafil—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	9.9e-05	0.00203	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	9.85e-05	0.00203	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	9.79e-05	0.00201	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—ALB—epilepsy syndrome	9.43e-05	0.00194	CbGpPWpGaD
Udenafil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	9.31e-05	0.00191	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	8.84e-05	0.00182	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CA13—epilepsy syndrome	7.7e-05	0.00158	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—SRC—epilepsy syndrome	6.67e-05	0.00137	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—VEGFA—epilepsy syndrome	6.5e-05	0.00134	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CERS1—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PDXK—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—FAR1—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ADK—epilepsy syndrome	5.84e-05	0.0012	CbGpPWpGaD
Udenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.34e-05	0.0011	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PNPO—epilepsy syndrome	5.34e-05	0.0011	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	5.34e-05	0.0011	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	5.34e-05	0.0011	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GAMT—epilepsy syndrome	5.34e-05	0.0011	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	5.23e-05	0.00108	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	5.2e-05	0.00107	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.16e-05	0.00106	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.13e-05	0.00105	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—QDPR—epilepsy syndrome	4.96e-05	0.00102	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CA4—epilepsy syndrome	4.96e-05	0.00102	CbGpPWpGaD
Udenafil—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	4.95e-05	0.00102	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	4.69e-05	0.000965	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—COX3—epilepsy syndrome	4.67e-05	0.000959	CbGpPWpGaD
Udenafil—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.63e-05	0.000952	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	4.42e-05	0.000909	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	4.42e-05	0.000909	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PFKL—epilepsy syndrome	4.42e-05	0.000909	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	4.42e-05	0.000909	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	4.42e-05	0.000909	CbGpPWpGaD
Udenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.33e-05	0.00089	CbGpPWpGaD
Udenafil—PDE5A—Hemostasis—AKT1—epilepsy syndrome	4.15e-05	0.000852	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NEU1—epilepsy syndrome	4.05e-05	0.000832	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—UPB1—epilepsy syndrome	4.05e-05	0.000832	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ATIC—epilepsy syndrome	4.05e-05	0.000832	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	3.89e-05	0.0008	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	3.76e-05	0.000773	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GBE1—epilepsy syndrome	3.76e-05	0.000773	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.58e-05	0.000736	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	3.54e-05	0.000727	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	3.44e-05	0.000707	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—NT5E—epilepsy syndrome	3.35e-05	0.000689	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ALAD—epilepsy syndrome	3.35e-05	0.000689	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	3.2e-05	0.000657	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	3.2e-05	0.000657	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	3.13e-05	0.000643	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ADSL—epilepsy syndrome	3.07e-05	0.00063	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GLUL—epilepsy syndrome	3.01e-05	0.000618	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	2.95e-05	0.000607	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	2.76e-05	0.000567	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.71e-05	0.000558	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AQP1—epilepsy syndrome	2.68e-05	0.000551	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.48e-05	0.00051	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.48e-05	0.00051	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.48e-05	0.00051	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.48e-05	0.00051	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	2.42e-05	0.000498	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	2.42e-05	0.000498	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.31e-05	0.000474	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.31e-05	0.000474	CbGpPWpGaD
Udenafil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.3e-05	0.000473	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.17e-05	0.000446	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.06e-05	0.000423	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.06e-05	0.000423	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.06e-05	0.000423	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.06e-05	0.000423	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.06e-05	0.000423	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.98e-05	0.000406	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.93e-05	0.000396	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.91e-05	0.000393	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.88e-05	0.000387	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.88e-05	0.000387	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.88e-05	0.000387	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.81e-05	0.000372	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.75e-05	0.000359	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.75e-05	0.000359	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.73e-05	0.000355	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.64e-05	0.000338	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.64e-05	0.000338	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.64e-05	0.000336	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.6e-05	0.000329	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.56e-05	0.000321	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.56e-05	0.00032	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.56e-05	0.00032	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.54e-05	0.000318	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—TH—epilepsy syndrome	1.54e-05	0.000316	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.49e-05	0.000306	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.49e-05	0.000306	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.46e-05	0.000299	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.43e-05	0.000293	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.4e-05	0.000287	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.37e-05	0.000282	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.28e-05	0.000264	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.28e-05	0.000264	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.27e-05	0.000261	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.25e-05	0.000256	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.23e-05	0.000253	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.15e-05	0.000236	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.13e-05	0.000232	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.13e-05	0.000232	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.01e-05	0.000207	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—APOE—epilepsy syndrome	9.85e-06	0.000202	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	9.19e-06	0.000189	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.95e-06	0.000184	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	8.9e-06	0.000183	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—POMC—epilepsy syndrome	8.46e-06	0.000174	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.03e-06	0.000165	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—ALB—epilepsy syndrome	7.71e-06	0.000159	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.64e-06	0.000157	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.61e-06	0.000156	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	7.26e-06	0.000149	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	7.18e-06	0.000148	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—TH—epilepsy syndrome	7.16e-06	0.000147	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.75e-06	0.000139	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.97e-06	0.000123	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.89e-06	0.000121	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.73e-06	0.000118	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.33e-06	0.00011	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.67e-06	9.6e-05	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.58e-06	9.41e-05	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.93e-06	8.08e-05	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.59e-06	7.37e-05	CbGpPWpGaD
Udenafil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.39e-06	6.97e-05	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.14e-06	6.45e-05	CbGpPWpGaD
Udenafil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.58e-06	3.24e-05	CbGpPWpGaD
